fbpx

340B Consulting

Our team of 340B Apexus Certified Experts can assist your covered entity with everything from implementation and compliance to revenue optimization. See our detailed services list below.

Services Overview

Compliance Services

As HRSA continues to scrutinize the program and increase the number of audits it performs, we can assist you in navigating the compliance requirements. Our services include:

  • Policies and Procedures review
  • Quarterly compliance monitoring
  • Annual compliance audits
  • HRSA audit preparation and on-site assistance
  • Patient definition review
  • Medicaid duplicate discount review
  • Staff education and training
  • Third-party system review and selection
  • New implementation guidance
  • IT data extracts and transfer

Revenue Optimization

We can assist you in making sure that you are receiving the optimal financial benefit from the 340B Program relative to the inherent compliance risks of participating in the program.

We are offering a Complimentary Financial Analysis of your 340B Retail Pharmacy Program. If you would like one of our 340B consultants to analyze your retail program for possible revenue opportunities, feel free to contact us.

340B Implementation Assistance

  • Provider-Based location development
  • Revenue analysis
  • Medicare cost report compilation
  • Contract pharmacy negotiation
  • 340B software selection
  • HRSA registration
  • Program monitoring
New Requirements by Humana for 340B Participants

New Requirements by Humana for 340B Participants

Attention 340B covered entities participating with Humana – Managed Care Medicare: Effective January 1, 2019, Humana requires that a “JG,” “TB,” or another relevant modifier be added to claims involving 340B eligible outpatient drugs under the Medicare Outpatient Prospective Payment System (OPPS) with status indicator “K.” If a claim does not include the proper modifier […]

Learn More
U.S. District Judge Rules 340B Cuts Exceeded HHS Authority

U.S. District Judge Rules 340B Cuts Exceeded HHS Authority

On December 28, 2018, a federal judge in Washington reversed the enormous cuts to Medicare OP Drug payments implemented by CMS which were effective January 1, 2018. U.S. District Judge Rudolph Contreras ruled CMS and HHS secretary exceeded their authority by cutting 340B reimbursement by approximately 28.5%. The Medicare OP Drug reimbursement methodology for certain hospitals […]

Learn More
Leveraging 340B Compliance to Improve Profitability

Leveraging 340B Compliance to Improve Profitability

Compliance is often a misunderstood word that most healthcare professionals associate with spending more time and money. Typically, compliance is defined as a certification or confirmation that the doer of an action or manufacturer of a product meets the requirements of accepted practices, legislation, prescribed regulations, specified standard or terms of a contract. 340B Program […]

Learn More

Connect with our team.

To learn more about our reimbursement services, contact our team here.

Send us a message.